Study of prostate-specific antigen levels during salvage radiotherapy after prostate cancer surgery

被引:2
作者
Aizawa, Takuya [1 ]
Maebayashi, Toshiya [1 ]
Ishibashi, Naoya [2 ]
Sakaguchi, Masakuni [1 ]
Sato, Akahiko [1 ]
Yamaguchi, Kenya [3 ]
机构
[1] Nihon Univ, Dept Radiol, Sch Med, Tokyo, Tokyo 1738610, Japan
[2] Nihon Univ Hosp, Dept Radiol, Chiyoda ku, Tokyo 1018309, Japan
[3] Nihon Univ Hosp, Dept Urol, Chiyoda ku, Tokyo 1018309, Japan
关键词
PSA; PSADT; Prostate cancer; Radiotherapy; Biochemical recurrence; RADICAL PROSTATECTOMY; BIOCHEMICAL RECURRENCE; ADJUVANT RADIOTHERAPY; RADIATION-THERAPY; FOLLOW-UP; PSA;
D O I
10.1186/s12894-023-01323-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
BackgroundAdministration of adjuvant or salvage radiotherapy (RT) after prostate cancer (PCa) surgery is supported by clinical evidence and is a widely adopted strategy. On occasion, we detect changes in prostate-specific antigen (PSA) levels, such as a transient elevation or decline, during RT. Thus, we retrospectively investigated the frequency of changes in PSA levels, their associations with histopathological parameters, PSA doubling time (PSADT), and biochemical recurrence (BR) of PCa.MethodsThis study included 23 consecutive patients who underwent surgery for PCa between 2012 and 2019, received salvage RT without hormone therapy, and exhibited changes in PSA levels during RT. The prostatic bed was irradiated with a total dose of 64 to 66 Gy. BR was defined as consecutive PSA levels exceeding 0.2 ng/mL or having to start hormone therapy because of PSA elevation after salvage RT.ResultsDuring salvage RT after PCa surgery, PSA levels transiently increased in 11 patients (47.8%) and decreased in 12 (52.2%). When factors associated with BR were examined in patients with transient PSA elevation, seminal vesicle invasion and preoperative PSA values were identified as being statistically significant. When factors for BR were examined in patients with a decline in PSA levels, the Gleason score and PSADT were identified as being significant. Among the cases of a decline in PSA levels during salvage RT, those who received a radiation dose of less than 36 Gy did not experience BR. Similarly, patients who exhibited changes in PSA levels during salvage RT and did not have perineural invasion did not experience BR.ConclusionThis is the first study to examine the histopathological factors possibly affecting BR in patients undergoing salvage RT after PCa surgery. The results indicate that in patients with transient PSA elevation, seminal vesicle invasion is a significant risk factor. On the other hand, in patients with a decline in PSA levels during irradiation, the Gleason score and perineural invasion were found to be potential risk factors for BR. These findings suggest that a thorough examination of postoperative histopathological results may be necessary for the optimal management of patients with PCa.
引用
收藏
页数:8
相关论文
共 26 条
[1]   Early PSA level decline is an independent predictor of biochemical and clinical control for salvage postprostatectomy radiotherapy [J].
Blanchard, Pierre ;
Bakkour, Moudar ;
De Crevoisier, Renaud ;
Levy, Antonin ;
Baumert, Herve ;
Patard, Jean-Jacques ;
Wibault, Pierre ;
Fizazi, Karim ;
Bossi, Alberto .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (03) :108.e15-108.e20
[2]   Postoperative radiotherapy after radical prostatectomy:: a randomised controlled trial (EORTC trial 22911) [J].
Bolla, M ;
van Poppel, H ;
Collette, L ;
van Cangh, P ;
Vekemans, K ;
Da Pozzo, L ;
de Reijke, TM ;
Verbaeys, A ;
Bosset, JF ;
van Velthoven, R ;
Maréchal, JM ;
Scalliet, P ;
Haustermans, K ;
Piérart, M .
LANCET, 2005, 366 (9485) :572-578
[3]   Interim Prostate-Specific Antigen: Predicting for Biochemical Failure During Salvage Radiation Therapy After Prostatectomy [J].
Cardoso, Michael ;
Ngo, Diana ;
Lim, Karen ;
Wong, Karen ;
Sidhom, Mark .
ADVANCES IN RADIATION ONCOLOGY, 2021, 6 (02)
[4]   Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial [J].
Carrie, Christian ;
Magne, Nicolas ;
Burban-Provost, Patricia ;
Sargos, Paul ;
Latorzeff, Igor ;
Lagrange, Jean-Leon ;
Supiot, Stephane ;
Belkacemi, Yazid ;
Peiffert, Didier ;
Allouache, Nedla ;
Dubray, Bernard M. ;
Servagi-Vernat, Stephanie ;
Suchaud, Jean-Philippe ;
Crehange, Gilles ;
Guerif, Stephane ;
Brihoum, Meryem ;
Barbier, Nicolas ;
Graff-Cailleaud, Pierre ;
Ruffion, Alain ;
Dussart, Sophie ;
Ferlay, Celine ;
Chabaud, Sylvie .
LANCET ONCOLOGY, 2019, 20 (12) :1740-1749
[5]   Serum PSA evaluations during salvage radiotherapy for post-prostatectomy biochemical failures as prognosticators for treatment outcomes [J].
Do, T ;
Dave, G ;
Parker, R ;
Kagan, AR .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (05) :1220-1225
[6]   Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy [J].
Eiber, Matthias ;
Maurer, Tobias ;
Souvatzoglou, Michael ;
Beer, Ambros J. ;
Ruffani, Alexander ;
Haller, Bernhard ;
Graner, Frank-Philipp ;
Kuebler, Hubert ;
Haberhorn, Uwe ;
Eisenhut, Michael ;
Wester, Hans-Juergen ;
Gschwend, Juergen E. ;
Schwaiger, Markus .
JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (05) :668-674
[7]   PSA after incidental irradiation of the nonmalignant prostate: Long-term changes [J].
Gripp, Stephan ;
Roos, Daniel ;
Rudoy, Michael ;
Matuschek, Christiane ;
Hermsen, Derik ;
Willers, Reinhardt ;
Budach, Wilfried ;
Boelke, Edwin .
STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 (10) :526-529
[8]   A prospective phase II study of prostate-specific antigen-guided salvage radiotherapy and 68Ga-PSMA-PET for biochemical relapse after radical prostatectomy-The PROPER 1 trial [J].
Gunnlaugsson, Adalsteinn ;
Johannesson, Vilberg ;
Wieslander, Elinore ;
Brun, Eva ;
Bitzen, Ulrika ;
Stahl, Olof ;
Bratt, Ola ;
Ahlgren, Goran ;
Ohlsson, Tomas ;
Kjellen, Elisabeth ;
Nilsson, Per .
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2022, 36 :77-82
[9]   PSA decay during salvage radiotherapy for prostate cancer as a predictor of disease outcome - 5 year follow-up of a prospective observational study [J].
Gunnlaugsson, Adalsteinn ;
Kjellen, Elisabeth ;
Bratt, Ola ;
Ahlgren, Goran ;
Johannesson, Vilberg ;
Blom, Rene ;
Nilsson, Per .
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2020, 24 :23-28
[10]   Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy - The 15-year Johns Hopkins experience [J].
Han, M ;
Partin, AW ;
Pound, CR ;
Epstein, JI ;
Walsh, PC .
UROLOGIC CLINICS OF NORTH AMERICA, 2001, 28 (03) :555-+